Infosys Foundation Diabetes Care Program to help in remission of Type 2 Diabetes – Nagpur News

 
In collaboration with ADORE, a second diabetes care center will be opened in Nagpur 
                                                                               
Nagpur – November 30, 2022: Infosys Foundation, the philanthropic and CSR arm of Infosys, today announced the opening of the second Diabetes Reversal Counseling Center in Nagpur, in collaboration with the Association for Diabetes and Obesity Reversal (ADORE). Earlier, Infosys Foundation had signed a Memorandum of Understanding (MoU) with ADORE to help in remission of type 2 diabetes in patients through lifestyle modifications. A sum of INR 2.4 crore was pledged towards this initiative, covering two centers in Pune and Nagpur for a period of three years. The Pune center started operations on 21^st November this year to mark World Diabetes Day.
 
The initiative is aimed at benefiting 12,000 patients over 3 years. Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others. Additionally, it intends to reduce the dose of diabetic medicines for a minimum of 50 percent of the patients.
 
The Diabetes Reversal Counseling Center in Nagpur, which is scheduled to commence operations from 1st December, will provide free counselling services to patients. The center will also conduct a free HbA1c testing camp for ten days from 5th to 14th December where people can register themselves for free testing. For name registration,Please WhatsApp on 88308 25209, 88308 24438 this number.
Center Address is as below:
Pingle Niwas, City Survey No. 948, Hingana Road, Deendayal Nagar, Nagpur
 
Sunil Kumar Dhareshwar, Trustee, Infosys Foundation, said, “We are extremely delighted to collaborate with ADORE to mitigate the effects of type 2 diabetes in thousands of patients. This synergy is driven by our shared vision to improve lives of patients by encouraging and enabling minor changes in their lifestyle. We are confident that these small steps, coupled with ADORE’s supervision and guidance, will bring about a colossal difference in their health.”
 
“We appreciate the support of Infosys Foundation as we strive to eradicate type-2 diabetes for patients in Pune and Nagpur. The soon-to-be-operational Nagpur center, manned with a diabetologist and counselor, will provide individual counseling and guidance. We hope to take this endeavor to greater heights to help better as many lives as possible”, said,Dr. Jagannath Dixit, Chairman of Association for Diabetes and Obesity Reversal (ADORE).
 
 
About Infosys Foundation
Established in 1996, the Infosys Foundation supports programs in the areas of education, rural development, healthcare, women empowerment, arts and culture, and destitute care. Its mission is to work with the underprivileged across the country and strive towards a more equitable society. The Infosys Foundation takes pride in working with all sections of society, selecting projects with infinite care, and working in areas that are traditionally overlooked by society at large.
 
For more details, please log on: https://www.infosys.com/infosys-foundation
 
About Infosys
Infosys is a global leader in next-generation digital services and consulting. Over 300,000 of our people work to amplify human potential and create the next opportunity for people, businesses, and communities. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, in more than 50 countries, as they navigate their digital transformation powered by the cloud. We enable them with an AI-powered core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.
 
Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.
 
Safe Harbor
Certain statements in this release concerning our future growth prospects, financial expectations and plans for navigating the COVID-19 impact on our employees, clients and stakeholders are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding COVID-19 and the effects of government and other measures seeking to contain its spread, risks related to an economic downturn or recession in India, the United States and other countries around the world, changes in political, business, and economic conditions, fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India and the US, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property and general economic conditions affecting our industry and the outcome of pending litigation and government investigation. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2022. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

source